Literature DB >> 6124962

Sulphasalazine-induced cerebral lupus erythematosus.

P Rafferty, A C Young, M R Haeney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6124962      PMCID： PMC2426286          DOI： 10.1136/pgmj.58.676.98

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  LUPUS ERYTHEMATOSUS CELL PHENOMENON IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

Authors:  D ALARCON SEGOVIA; T HERSKOVIC; W H DEARING; L G BARTHOLOMEW; J C CAIN; R G SHORTER
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

2.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

3.  Central nervous system lupus--diagnosis and treatment.

Authors:  G R Hughes
Journal:  J Rheumatol       Date:  1980 May-Jun       Impact factor: 4.666

4.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

5.  Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjögren's syndrome.

Authors:  A J Crisp; B I Hoffbrand
Journal:  J R Soc Med       Date:  1980-01       Impact factor: 18.000
  5 in total
  2 in total

1.  Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment.

Authors:  K Wildhagen; K Hartung; M Hammer; W Mau; R E Schmidt; H Deicher; H Zeidler
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

2.  Sensorimotor neuropathy with sulphasalazine.

Authors:  T R Price
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.